ABL Bio Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	8,829,223	11,025,033	1,443,630	1,178,156	1,099,129	1,041,424
Market Cap Growth	360.05%	663.70%	22.53%	7.19%	5.54%	-
Enterprise Value	8,771,583	10,941,258	1,335,337	1,126,398	1,038,936	-
Last Close Price	157700.00	200000.00	29900.00	24600.00	23000.00	22100.00
PE Ratio	-	-	-	-	342.55	-
PS Ratio	111.27	138.94	43.22	17.97	16.33	195.31
PB Ratio	56.35	70.36	8.63	15.90	15.81	18.61
P/TBV Ratio	58.14	72.60	8.91	16.47	16.43	19.50
P/FCF Ratio	-	-	-	-	15.69	-
P/OCF Ratio	-	-	-	-	15.24	-
EV/Sales Ratio	110.54	137.89	39.98	17.18	15.44	-
EV/EBITDA Ratio	-	-	-	-	321.37	-
EV/EBIT Ratio	-	-	-	-	1144.20	-
EV/FCF Ratio	-143.05	-	-	-	14.83	-
Debt / Equity Ratio	0.35	0.35	0.26	0.59	0.60	0.01
Debt / EBITDA Ratio	-	-	-	-	12.94	-
Debt / FCF Ratio	-	-	-	-	0.60	-
Net Debt / Equity Ratio	-0.38	-0.38	-0.58	-0.37	-0.52	-0.77
Net Debt / EBITDA Ratio	1.61	1.61	1.72	996.51	-11.28	0.88
Net Debt / FCF Ratio	0.97	0.97	1.25	0.80	-0.52	1.03
Asset Turnover	0.31	0.31	0.17	0.38	0.54	-
Quick Ratio	1.41	1.41	2.24	1.71	1.09	5.01
Current Ratio	1.43	1.43	2.28	1.81	1.12	5.20
Return on Equity (ROE)	-23.38%	-23.38%	-46.01%	-3.69%	5.12%	-
Return on Assets (ROA)	-9.84%	-9.84%	-18.93%	-0.95%	0.45%	-
Return on Capital Employed (ROCE)	-25.70%	-25.70%	-35.20%	-2.20%	0.80%	-90.30%
Earnings Yield	-0.43%	-0.34%	-3.85%	-0.22%	0.29%	-4.18%
FCF Yield	-0.69%	-0.56%	-5.43%	-2.90%	6.38%	-4.02%
Buyback Yield / Dilution	-7.25%	-7.25%	-0.37%	-0.58%	-1.27%	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.